“…One type of infection that is currently very prominent is exposure to the SARS-CoV-2 coronavirus, the cause for COVID-19. It has been linked to a greater risk for severe PE [ 135 , 136 , 137 , 138 ]. It was recently reviewed that almost 38% of pregnancies infected by COVID-19 have markers of uteroplacental malperfusion, including fibrin deposition, infarction, decidual vasculopathy, accelerated villous hyperplasia, distal villous hypoplasia, and retroplacental hemorrhage, as well as placental inflammation [ 139 , 140 ].…”